Taiwanese Pharmaceuticals & Biotech Profitable Climbers

PharmaEssentia

Market Cap: NT$518.4b

A biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan.

Bora Pharmaceuticals

Market Cap: NT$56.0b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

Lotus Pharmaceutical

Market Cap: NT$52.4b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.